Company Filing History:

13 out of 2,405

Merck Sharp + Dohme Corp.

where one patent can have more than one assignee

Years Active: 2016-2020

Loading Chart...

13 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 10745364 - Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease (2020-08-18),

2. 10221146 - Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease (2019-03-05),

3. 10196354 - 4-heteroaryl substituted benzoic acid compounds as RORgammaT inhibitors and uses thereof (2019-02-05),

4. 9844553 - Pyrazolopyridyl compounds as aldosterone synthase inhibitors (2017-12-19),

5. 9809561 - Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease (2017-11-07),

6. 9783511 - Carbamate benzoxazine propionic acids and acid derivatives for modulation of RORgamma activity and the treatment of disease (2017-10-10),

7. 9745265 - 4-heteroaryl substituted benzoic acid compounds as RORgammaT inhibitors and uses thereof (2017-08-29),

8. 9663522 - 3-aminocycloalkyl compounds as RORgammaT inhibitors and uses thereof (2017-05-30),

9. 9663502 - 2-Acylamidomethyl and sulfonylamidomethyl benzoxazine carbamates for inhibition of RORgamma activity and the treatment of disease (2017-05-30),

10. 9567333 - Triazolopyridyl compounds as aldosterone synthase inhibitors (2017-02-14),

11. 9556168 - N-alkylated indole and indazole compounds as RORgammaT inhibitors and uses thereof (2017-01-31),

12. 9518055 - Imidazopyridyl compounds as aldosterone synthase inhibitors (2016-12-13),

13. 9487490 - 3-cyclohexenyl and cyclohexyl substituted indole and indazole compounds as RORgammaT inhibitors and uses thereof (2016-11-08),

Title: John K MacLean: Innovator in Pharmaceutical Compounds

Introduction

John K MacLean is a notable inventor based in Brookline, MA (US), recognized for his contributions to the field of pharmaceutical compounds. With a total of 13 patents to his name, he has made significant strides in the development of innovative treatments for various diseases.

Latest Patents

Among his latest patents are the inventions related to tetrahydronaphthyridine, benzoxazine, aza-benzoxazine, and related bicyclic compounds aimed at inhibiting RORgamma activity. These inventions provide certain bicyclic heterocyclic compounds of the Formula (I) or pharmaceutically acceptable salts thereof. The patents also include pharmaceutical compositions comprising such compounds and methods for using them to treat diseases or conditions mediated by RORgammaT.

Career Highlights

Throughout his career, John K MacLean has worked with prominent companies such as Merck Sharp & Dohme Corporation and Lycera Corporation. His work in these organizations has contributed to advancements in pharmaceutical research and development.

Collaborations

Some of his notable coworkers include Kenneth Jay Barr and Neville J Anthony, who have collaborated with him on various projects in the pharmaceutical field.

Conclusion

John K MacLean's innovative work in the development of pharmaceutical compounds has made a significant impact on the treatment of diseases. His contributions continue to influence the field and pave the way for future advancements.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.